"immune checkpoint" trang 5 - tải miễn phí từ tailieunhanh
Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures

Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures
25    17    3
Complete response to combination therapy using nivolumab and ipilimumab for metastatic, sarcomatoid collecting duct carcinoma presenting with high expression of programmed death-ligand 1: A case report

Complete response to combination therapy using nivolumab and ipilimumab for metastatic, sarcomatoid collecting duct carcinoma presenting with high expression of programmed death-ligand 1: A case report
7    1    1
Pembrolizumab-induced myasthenia gravis and myositis: Literature review on neurological toxicities of programmed death protein 1 inhibitors

Pembrolizumab-induced myasthenia gravis and myositis: Literature review on neurological toxicities of programmed death protein 1 inhibitors
6    3    1
Sarcoid-like granulomatosis of the lung related to durvalumab after chemoradiation for pulmonary squamous cell carcinoma

Sarcoid-like granulomatosis of the lung related to durvalumab after chemoradiation for pulmonary squamous cell carcinoma
6    6    1
Durvalumab for extensive stage of small-cell lung cancer with lambert-eaton myasthenic syndrome

Durvalumab for extensive stage of small-cell lung cancer with lambert-eaton myasthenic syndrome
5    6    1
Integrated bioinformatics analysis and experimental validation reveal ISG20 as a novel prognostic indicator expressed on M2 macrophage in glioma

Integrated bioinformatics analysis and experimental validation reveal ISG20 as a novel prognostic indicator expressed on M2 macrophage in glioma
15    1    1
A phase Ib/II study of galunisertib in combination with nivolumab in solid tumors and non-small cell lung cancer

A phase Ib/II study of galunisertib in combination with nivolumab in solid tumors and non-small cell lung cancer
13    1    1
Genome instability-related LINC02577, LINC01133 and AC107464.2 are lncRNA prognostic markers correlated with immune microenvironment in pancreatic adenocarcinoma

Genome instability-related LINC02577, LINC01133 and AC107464.2 are lncRNA prognostic markers correlated with immune microenvironment in pancreatic adenocarcinoma
21    4    1
Pan-cancer analysis of TASL: A novel immune infiltration-related biomarker for tumor prognosis and immunotherapy response prediction

Pan-cancer analysis of TASL: A novel immune infiltration-related biomarker for tumor prognosis and immunotherapy response prediction
22    3    1
MEX3C as a potential target for hepatocellular carcinoma drug and immunity: Combined therapy with Lenvatinib

MEX3C as a potential target for hepatocellular carcinoma drug and immunity: Combined therapy with Lenvatinib
13    4    1
Expression of PD1 and PDL1 as immune-checkpoint inhibitors in mantle cell lymphoma

Expression of PD1 and PDL1 as immune-checkpoint inhibitors in mantle cell lymphoma
8    1    1
The acidic tumor microenvironment enhances PD-L1 expression via activation of STAT3 in MDA-MB-231 breast cancer cells

The acidic tumor microenvironment enhances PD-L1 expression via activation of STAT3 in MDA-MB-231 breast cancer cells
11    4    1
Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinoma

Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinoma
15    1    1
Metachronous immune-related adverse events involving type 1 diabetes and isolated adrenocorticotropic hormone deficiency associated with pembrolizumab monotherapy for metastatic head and neck cancer: A case report

Metachronous immune-related adverse events involving type 1 diabetes and isolated adrenocorticotropic hormone deficiency associated with pembrolizumab monotherapy for metastatic head and neck cancer: A case report
6    15    1
Checkpoint inhibitors in metastatic gastric and GEJ cancer: A multi-institutional retrospective analysis of real-world data in a Western cohort

Checkpoint inhibitors in metastatic gastric and GEJ cancer: A multi-institutional retrospective analysis of real-world data in a Western cohort
10    39    3
Favorable response to pembrolizumab after durvalumab failure in a stage III sarcomatoid carcinoma of the lung: A case report

Favorable response to pembrolizumab after durvalumab failure in a stage III sarcomatoid carcinoma of the lung: A case report
4    80    0
CD73 blockade enhances the local and abscopal effects of radiotherapy in a murine rectal cancer model

CD73 blockade enhances the local and abscopal effects of radiotherapy in a murine rectal cancer model
12    56    0
Dissociated responses at initial computed tomography evaluation is a good prognostic factor in non-small cell lung cancer patients treated with antiprogrammed cell death-1/ligand 1 inhibitors

Dissociated responses at initial computed tomography evaluation is a good prognostic factor in non-small cell lung cancer patients treated with antiprogrammed cell death-1/ligand 1 inhibitors
8    92    0
Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation

Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation
10    74    0
A prospective observational study to assess PD-L1 expression in small biopsy samples for non-small-cell lung cancer

A prospective observational study to assess PD-L1 expression in small biopsy samples for non-small-cell lung cancer
8    85    0